These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 23893923)

  • 1. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
    Vignot S; Frampton GM; Soria JC; Yelensky R; Commo F; Brambilla C; Palmer G; Moro-Sibilot D; Ross JS; Cronin MT; André F; Stephens PJ; Lazar V; Miller VA; Brambilla E
    J Clin Oncol; 2013 Jun; 31(17):2167-72. PubMed ID: 23630207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma.
    DiBardino DM; Saqi A; Elvin JA; Greenbowe J; Suh JH; Miller VA; Ali SM; Stoopler M; Bulman WA
    Clin Lung Cancer; 2016 Nov; 17(6):517-522.e3. PubMed ID: 27378171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
    Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
    da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
    Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.
    Scheffler M; Bos M; Gardizi M; König K; Michels S; Fassunke J; Heydt C; Künstlinger H; Ihle M; Ueckeroth F; Albus K; Serke M; Gerigk U; Schulte W; Töpelt K; Nogova L; Zander T; Engel-Riedel W; Stoelben E; Ko YD; Randerath W; Kaminsky B; Panse J; Becker C; Hellmich M; Merkelbach-Bruse S; Heukamp LC; Büttner R; Wolf J
    Oncotarget; 2015 Jan; 6(2):1315-26. PubMed ID: 25473901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
    Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
    Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
    Karnes HE; Duncavage EJ; Bernadt CT
    Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management.
    Valero V; Saunders TJ; He J; Weiss MJ; Cameron JL; Dholakia A; Wild AT; Shin EJ; Khashab MA; O'Broin-Lennon AM; Ali SZ; Laheru D; Hruban RH; Iacobuzio-Donahue CA; Herman JM; Wolfgang CL
    Ann Surg; 2016 Jan; 263(1):153-61. PubMed ID: 26020105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
    Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
    Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome profiling of pancreatic adenocarcinoma.
    Birnbaum DJ; Adélaïde J; Mamessier E; Finetti P; Lagarde A; Monges G; Viret F; Gonçalvès A; Turrini O; Delpero JR; Iovanna J; Giovannini M; Birnbaum D; Chaffanet M
    Genes Chromosomes Cancer; 2011 Jun; 50(6):456-65. PubMed ID: 21412932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of fine-needle aspiration in the diagnosis of primary and metastatic tumors to the lung: a retrospective examination of 1,032 cases.
    Adams J; Wu HH
    Acta Cytol; 2012; 56(6):590-5. PubMed ID: 23207436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the mitochondrial displacement loop in lung cancers.
    Suzuki M; Toyooka S; Miyajima K; Iizasa T; Fujisawa T; Bekele NB; Gazdar AF
    Clin Cancer Res; 2003 Nov; 9(15):5636-41. PubMed ID: 14654546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alteration profiling of patients with resected squamous cell lung carcinomas.
    Tao D; Han X; Zhang N; Lin D; Wu D; Zhu X; Song W; Shi Y
    Oncotarget; 2016 Jun; 7(24):36590-36601. PubMed ID: 27145277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
    Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
    Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.